Core Viewpoint - Lake Medical Industries (LAKE.US) experienced a significant pre-market decline of 22.7% to $11.6 following the announcement of a substantial earnings miss for Q3 of fiscal year 2025, with a diluted net loss per share of $1.64 compared to analyst expectations of a profit of $0.23 and a prior year earnings of $0.01 [1] Financial Performance - The company reported a diluted net loss per share of $1.64 for Q3 of fiscal year 2025, which is a significant deviation from analyst expectations of a profit of $0.23 [1] - The previous year's earnings were reported at $0.01 per share, indicating a substantial decline in performance year-over-year [1] Future Outlook - Due to various macroeconomic factors, the company has decided to withdraw its previously issued guidance for fiscal year 2026 and will not provide future financial guidance [1]
美股异动丨雷克兰医疗工业盘前大跌近23% Q3业绩亏损,撤回2026财年展望